D
Terns Pharmaceuticals, Inc. TERN
$3.04 $0.041.33% NASDAQ
Recommendation
Prev Close
$3.04
Volume
905,020
Avg Vol (90D)
1,347,564
Market Cap
$265.50M
Dividend & Yield
--
52-Week Range
$1.87 - $11.40
P/E (TTM)
--
EPS (TTM)
-$1.13
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Terns Pharmaceuticals (TERN, $3.04) Aroon Indicator entered an Uptrend on May 09, 2025.
5/10/2025 - Tickeron - Technical Analysis
Terns Pharmaceuticals GAAP EPS of -$0.26
5/9/2025 - SeekingAlpha.com: All News
Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030?
5/9/2025 - Insider Monkey
10 Low Risk High Reward Stocks Set to Triple by 2030
5/9/2025 - Insider Monkey
Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
5/8/2025 - GuruFocus
Terns Pharmaceuticals reports Q1 EPS (26c), consensus (27c)
5/8/2025 - The Fly
Terns Pharmaceuticals files $300M mixed securities shelf
5/8/2025 - The Fly
Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
5/8/2025 - Globe Newswire
Terns Pharmaceuticals (TERN, $3.03) Aroon Indicator entered an Uptrend on May 07, 2025.
5/8/2025 - Tickeron - Stocks
Terns Pharmaceuticals (TERN) to Post Earnings on Monday
5/7/2025 - MarketBeat
Terns Pharmaceuticals (TERN, $3.01) Aroon Indicator entered an Uptrend on May 06, 2025.
5/7/2025 - Tickeron - Stocks
Terns Pharmaceuticals (TERN, $3.01) price exceeded its 50-day Moving Average on May 06, 2025
5/7/2025 - Tickeron - Stocks
Terns Pharmaceuticals (TERN, $3.3) RSI Indicator left the overbought zone on May 05, 2025
5/6/2025 - Tickeron - Technical Analysis
JPMorgan Chase & Co. Reduces Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
5/5/2025 - MarketBeat
Boxer Capital Management LLC Takes $4.17 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
5/4/2025 - MarketBeat
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ...
5/2/2025 - GuruFocus
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ...
5/2/2025 - GuruFocus
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
5/2/2025 - Globe Newswire
Terns Pharmaceuticals (TERN, $3.56) RSI Indicator left the overbought zone on May 01, 2025
5/2/2025 - Tickeron - Technical Analysis
Acuta Capital Partners LLC Sells 39,500 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
5/2/2025 - Ticker Report
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Schonfeld Strategic Advisors LLC
5/1/2025 - MarketBeat
Terns Pharmaceuticals (TERN, $3.3) RSI Indicator left the overbought zone on April 30, 2025
5/1/2025 - Tickeron - Stocks
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
4/30/2025 - GuruFocus
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
4/30/2025 - Globe Newswire
Oxford Asset Management LLP Takes $86,000 Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
4/29/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$101.55M
EBIT (TTM)
-$101.87M
Net Income (TTM)
-$88.85M
Balance Sheet
Total Assets (Q)
$363.93M
Total Debt (Q)
$1.35M
Total Liabilities (Q)
$18.06M
Book Value Per Share (Q)
$3.97
Cash Flow
Cash from Operations (TTM)
-$70.02M
Cash from Investing (TTM)
-$12.41M
Cash from Financing (TTM)
$164.00M
Net Change in Cash (TTM)
$81.51M
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
1.61
7-Day Total Return
-14.61%
30-Day Total Return
4.11%
60-Day Total Return
-25.49%
90-Day Total Return
-45.03%
Year to Date Total Return
-46.38%
1-Year Total Return
-45.32%
2-Year Total Return
-76.62%
3-Year Total Return
87.65%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $1.87
52-week High
Sep 10, 2024 - $11.40
Valuation
Market Cap
$265.50M - Micro Cap
Enterprise Value
-$67.53M
Price/Sales (TTM)
--
Price/Book (Q)
0.77
Dividends and Shares
Shares Outstanding
91.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.ternspharma.com
Phone Number
650 525 5535
Address
1065 East Hillsdale Boulevard
Foster City, CA 94404
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an... more
NASDAQ 05/09/2025 4:00PM Eastern Quotes delayed